Ellen C Ordinario

Title: Innovations by Ellen C Ordinario

Introduction

Ellen C Ordinario is a notable inventor based in Oakland, CA, who has made significant contributions to the field of molecular biology. With a total of 3 patents, her work focuses on the detection of gene fusions and the evaluation of cancer aggressiveness.

Latest Patents

One of her latest patents is titled "Multiplex PCR detection of ALK, RET, and ROS fusions." This invention provides methods and compositions for the multiplex detection of a large number of actionable gene fusions with very high sensitivity and specificity. The methods can detect ALK, RET, and ROS1 gene fusions, optionally in combination with other mutations and fusions. Another significant patent is related to "Long non-coding RNA expressed in aggressive cancer." This invention offers methods and compositions for evaluating levels of long non-coding RNA to assess the aggressiveness of cancer and for modulating its levels.

Career Highlights

Ellen has worked with prominent organizations such as Roche Molecular Systems, Inc. and the University of California. Her experience in these institutions has allowed her to develop innovative solutions in cancer research and diagnostics.

Collaborations

Ellen has collaborated with notable colleagues, including Ann Begovich and Dwight Kuo, contributing to advancements in her field.

Conclusion

Ellen C Ordinario's innovative work in molecular biology and cancer research has led to significant advancements in the detection and evaluation of cancer-related gene fusions. Her contributions continue to impact the scientific community and improve diagnostic methods.